These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 19957330

  • 1. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
    Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F.
    Int J Cancer; 2010 Aug 01; 127(3):568-77. PubMed ID: 19957330
    [Abstract] [Full Text] [Related]

  • 2. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
    Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP.
    Cancer Res; 2002 Nov 15; 62(22):6442-6. PubMed ID: 12438232
    [Abstract] [Full Text] [Related]

  • 3. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
    Tian F, Tang Z, Song G, Pan Y, He B, Bao Q, Wang S.
    Mol Med Rep; 2012 Jun 15; 5(6):1536-40. PubMed ID: 22427002
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H, Higashimoto K, Aoki S, Mishima H, Hayashida C, Maeda T, Koga Y, Yatsuki H, Joh K, Noshiro H, Iwakiri R, Kawaguchi A, Yoshiura KI, Fujimoto K, Soejima H.
    Clin Epigenetics; 2018 Dec 04; 10(1):150. PubMed ID: 30509319
    [Abstract] [Full Text] [Related]

  • 5. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
    Baba Y, Nosho K, Shima K, Huttenhower C, Tanaka N, Hazra A, Giovannucci EL, Fuchs CS, Ogino S.
    Gastroenterology; 2010 Dec 04; 139(6):1855-64. PubMed ID: 20682317
    [Abstract] [Full Text] [Related]

  • 6. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T, Yoshie M, Yaginuma Y, Tanaka T, Ogawa K.
    J Biol Chem; 2003 Feb 21; 278(8):6222-8. PubMed ID: 12475990
    [Abstract] [Full Text] [Related]

  • 7. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
    Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S, Kaneko Y.
    Br J Cancer; 2008 Dec 02; 99(11):1891-9. PubMed ID: 19034281
    [Abstract] [Full Text] [Related]

  • 8. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M, Hoffman AR.
    Hum Mol Genet; 2003 Mar 01; 12(5):535-49. PubMed ID: 12588801
    [Abstract] [Full Text] [Related]

  • 9. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S.
    Clin Transl Oncol; 2014 Apr 01; 16(4):410-7. PubMed ID: 23943562
    [Abstract] [Full Text] [Related]

  • 10. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
    Cruz-Correa M, Zhao R, Oviedo M, Bernabe RD, Lacourt M, Cardona A, Lopez-Enriquez R, Wexner S, Cuffari C, Hylind L, Platz E, Cui H, Feinberg AP, Giardiello FM.
    Epigenetics; 2009 Feb 16; 4(2):114-8. PubMed ID: 19242102
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.
    Pan Y, He B, Chen J, Sun H, Deng Q, Wang F, Ying H, Liu X, Lin K, Peng H, Xie H, Wang S.
    Int J Oncol; 2015 Nov 16; 47(5):1881-9. PubMed ID: 26397886
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT, Brown LJ, Fallin MD, Rongione MA, Bibikova M, Wickham E, Fan JB, Feinberg AP.
    J Natl Cancer Inst; 2007 Aug 15; 99(16):1270-3. PubMed ID: 17686827
    [Abstract] [Full Text] [Related]

  • 13. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
    Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston JE, Uribe-Lewis S, Woodfine K, Jagodic M, Nativio R, Dunning A, Moore G, Klenova E, Bingham S, Pharoah PD, Brenton JD, Beck S, Sandhu MS, Murrell A.
    Hum Mol Genet; 2008 Sep 01; 17(17):2633-43. PubMed ID: 18541649
    [Abstract] [Full Text] [Related]

  • 14. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A.
    Mol Cancer Res; 2006 Apr 01; 4(4):283-92. PubMed ID: 16603642
    [Abstract] [Full Text] [Related]

  • 15. Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2.
    Yamaguchi Y, Tayama C, Tomikawa J, Akaishi R, Kamura H, Matsuoka K, Wake N, Minakami H, Kato K, Yamada T, Nakabayashi K, Hata K.
    Clin Epigenetics; 2019 Aug 01; 11(1):113. PubMed ID: 31370882
    [Abstract] [Full Text] [Related]

  • 16. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
    Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim JM, Oh YK.
    Biochim Biophys Acta; 2002 Apr 24; 1586(3):307-15. PubMed ID: 11997082
    [Abstract] [Full Text] [Related]

  • 17. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.
    Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A.
    Proc Natl Acad Sci U S A; 2001 Jan 16; 98(2):591-6. PubMed ID: 11120891
    [Abstract] [Full Text] [Related]

  • 18. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
    Belharazem D, Magdeburg J, Berton AK, Beissbarth L, Sauer C, Sticht C, Marx A, Hofheinz R, Post S, Kienle P, Ströbel P.
    J Gastroenterol; 2016 Oct 16; 51(10):971-84. PubMed ID: 26984550
    [Abstract] [Full Text] [Related]

  • 19. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stéhelin D, Coll J, Riou G.
    Oncogene; 1996 Jan 18; 12(2):423-30. PubMed ID: 8570220
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER.
    Br J Cancer; 2005 Apr 25; 92(8):1574-80. PubMed ID: 15798773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.